In this study, we report a prognostic role for pERK levels in lung adenocarcinoma, and we demonstrate that nuclear p53 expression is a potential prognostic biomarker in lung squamous cell carcinoma patients, where it is associated with poorer tumor differentiation. This evidence concerns the gene TP53 and lung adenocarcinoma.